{"date":"2025-08-26","count":24,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6483-2025-08-26-2250-t44vrg","company_id":"6483","company":"原創生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-26","time":"22:50:16","subject":"公告修正本公司114年度股東會議事手冊及議事錄部分內容","clause":"第44款","fact_date":"2025-08-26","cite_as":"公開資訊觀測站重大訊息：原創生醫（6483），2025-08-26 22:50，「公告修正本公司114年度股東會議事手冊及議事錄部分內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2025-08-26-1843-t3zy9d","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2025-08-26","time":"18:43:47","subject":"公告本公司因有價證券於櫃買市場達公布注意交易資訊標準，公布相關財務業務資訊","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2025-08-26 18:43，「公告本公司因有價證券於櫃買市場達公布注意交易資訊標準，公布相關財務業務資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2025-08-26-1810-1mrkp1z","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2025-08-26","time":"18:10:59","subject":"代子公司廣州漢科生物有限公司 依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第三款規定公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2025-08-26 18:10，「代子公司廣州漢科生物有限公司 依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第三款規定公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2025-08-26-1804-ywsvm8","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2025-08-26","time":"18:04:20","subject":"本公司董事會決議現金增資子公司北京健達康新藥開發有限公司","clause":"第20款","fact_date":"2025-08-26","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2025-08-26 18:04，「本公司董事會決議現金增資子公司北京健達康新藥開發有限公司」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2025-08-26-1804-g0jfn4","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2025-08-26","time":"18:04:03","subject":"本公司董事會決議現金增資台灣子公司共信寵物生醫股份有限公司","clause":"第20款","fact_date":"2025-08-26","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2025-08-26 18:04，「本公司董事會決議現金增資台灣子公司共信寵物生醫股份有限公司」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2025-08-26-1803-xyhazt","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2025-08-26","time":"18:03:41","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2025-08-26 18:03，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4148-2025-08-26-1754-z351id","company_id":"4148","company":"全宇生技-KY","market":"上市","industry":"生技醫療","date":"2025-08-26","time":"17:54:42","subject":"代子公司全宇工業有限公司依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第三款之規定公告","clause":"第23款","fact_date":"2025-08-26","cite_as":"公開資訊觀測站重大訊息：全宇生技-KY（4148），2025-08-26 17:54，「代子公司全宇工業有限公司依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第三款之規定公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4148-2025-08-26-1754-kgzzyx","company_id":"4148","company":"全宇生技-KY","market":"上市","industry":"生技醫療","date":"2025-08-26","time":"17:54:08","subject":"董事會決議不分派半年度股利","clause":"第14款","fact_date":"2025-08-26","cite_as":"公開資訊觀測站重大訊息：全宇生技-KY（4148），2025-08-26 17:54，「董事會決議不分派半年度股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4148-2025-08-26-1742-aa2zln","company_id":"4148","company":"全宇生技-KY","market":"上市","industry":"生技醫療","date":"2025-08-26","time":"17:42:35","subject":"公告本公司董事會通過114年第2季合併財務報告","clause":"第31款","fact_date":"2025-08-26","cite_as":"公開資訊觀測站重大訊息：全宇生技-KY（4148），2025-08-26 17:42，「公告本公司董事會通過114年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4163-2025-08-26-1718-rxx7eg","company_id":"4163","company":"鐿鈦","market":"上櫃","industry":"生技醫療","date":"2025-08-26","time":"17:18:18","subject":"公告本公司註銷收回限制員工權利新股辦理變更登記完成","clause":"第36款","fact_date":"2025-08-26","cite_as":"公開資訊觀測站重大訊息：鐿鈦（4163），2025-08-26 17:18，「公告本公司註銷收回限制員工權利新股辦理變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-08-26-1641-1un8qze","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-08-26","time":"16:41:52","subject":"代重要子公司鼎晉生技公告，OBI-858新型肉毒桿菌素二期臨床試驗最終分析結果正面，其試驗之主要及次要療效指標均達統計上顯著意義。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-08-26 16:41，「代重要子公司鼎晉生技公告，OBI-858新型肉毒桿菌素二期臨床試驗最終分析結果正面，其試驗之主要及次要療效指標均達統計上」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7784-2025-08-26-1603-1ts6xxq","company_id":"7784","company":"安邦生技*","market":"興櫃","industry":"生技醫療","date":"2025-08-26","time":"16:03:31","subject":"公告本公司董事會決議通過技術長任命案。","clause":"第6款","fact_date":"2025-08-26","cite_as":"公開資訊觀測站重大訊息：安邦生技*（7784），2025-08-26 16:03，「公告本公司董事會決議通過技術長任命案。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4142-2025-08-26-1552-1twga2x","company_id":"4142","company":"國光生","market":"上市","industry":"生技醫療","date":"2025-08-26","time":"15:52:59","subject":"公告本公司潭子廠獲得巴西國家衛生監督局(ANVISA)GMP證書","clause":"第51款","fact_date":"2025-08-26","cite_as":"公開資訊觀測站重大訊息：國光生（4142），2025-08-26 15:52，「公告本公司潭子廠獲得巴西國家衛生監督局(ANVISA)GMP證書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2025-08-26-1531-qkrt5g","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2025-08-26","time":"15:31:10","subject":"公告本公司股務代理機構名稱、辦公處所及聯絡電話","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2025-08-26 15:31，「公告本公司股務代理機構名稱、辦公處所及聯絡電話」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2025-08-26-1531-ixqic3","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2025-08-26","time":"15:31:01","subject":"公告本公司股票初次上巿現金增資認股繳款期間暨暫定承銷價相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2025-08-26 15:31，「公告本公司股票初次上巿現金增資認股繳款期間暨暫定承銷價相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2025-08-26-1530-14246kr","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2025-08-26","time":"15:30:54","subject":"公告本公司114年07月份自結合併財務報告之負債比率、流動比率及速動比率","clause":"第53款","fact_date":"2025-08-26","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2025-08-26 15:30，「公告本公司114年07月份自結合併財務報告之負債比率、流動比率及速動比率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2025-08-26-1530-1mlfoxc","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2025-08-26","time":"15:30:15","subject":"公告本公司與佳世達集團南京明基醫院簽訂加速器硼中子捕獲治療中心建置合作協議","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2025-08-26 15:30，「公告本公司與佳世達集團南京明基醫院簽訂加速器硼中子捕獲治療中心建置合作協議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2025-08-26-1519-1hkj5dk","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2025-08-26","time":"15:19:26","subject":"係因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2025-08-26 15:19，「係因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2025-08-26-1518-1kbupvl","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2025-08-26","time":"15:18:55","subject":"公告修正本公司113年度股東會年報部分內容","clause":"第50款","fact_date":"2025-08-26","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2025-08-26 15:18，「公告修正本公司113年度股東會年報部分內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2025-08-26-1454-isqttc","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2025-08-26","time":"14:54:01","subject":"公告本公司董事會重要決議事項","clause":"第44款","fact_date":"2025-08-26","cite_as":"公開資訊觀測站重大訊息：普生（4117），2025-08-26 14:54，「公告本公司董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2025-08-26-1408-1mfp6d1","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2025-08-26","time":"14:08:09","subject":"公告本公司國內第二次無擔保可轉換公司債終止上櫃暨到期還本事宜","clause":"第53款","fact_date":"2025-08-26","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2025-08-26 14:08，「公告本公司國內第二次無擔保可轉換公司債終止上櫃暨到期還本事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4120-2025-08-26-1358-vqd6ih","company_id":"4120","company":"友華","market":"上櫃","industry":"生技醫療","date":"2025-08-26","time":"13:58:47","subject":"公告本公司將於114年08月27日召開線上法人說明會","clause":"第12款","fact_date":"2025-08-27","cite_as":"公開資訊觀測站重大訊息：友華（4120），2025-08-26 13:58，「公告本公司將於114年08月27日召開線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3164-2025-08-26-1349-8pje34","company_id":"3164","company":"景岳","market":"上市","industry":"生技醫療","date":"2025-08-26","time":"13:49:50","subject":"公告本公司註銷庫藏股減資辦理資本變更登記完成","clause":"第36款","fact_date":"2025-08-25","cite_as":"公開資訊觀測站重大訊息：景岳（3164），2025-08-26 13:49，「公告本公司註銷庫藏股減資辦理資本變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2025-08-26-0828-qrbd3s","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2025-08-26","time":"08:28:51","subject":"本公司前列腺癌新劑型新藥 CAMCEVI 三個月劑型通過美國FDA新藥申請審查核可","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2025-08-26 08:28，「本公司前列腺癌新劑型新藥 CAMCEVI 三個月劑型通過美國FDA新藥申請審查核可」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}